General practitioners’ adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark

References

• Konstantin Nissen N, Rasmussen S. Hjertestatistik 2008 – fokus på køn og sociale forhold [Heart statistics 2008 – focus on gender and socioeconomics], København: Hjerteforeningen; 2008.
   Google Scholar
• Prevention of cardiovascular disease: Guideline for assessment and management of cardiovascular risk. Geneva: World Health Organization; 2007.
   Google Scholar
• Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, . Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.
   PubMed Web of Science ®Google Scholar
• Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008;52:1769–81.
   PubMed Web of Science ®Google Scholar
• World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988;41:105–14.
   PubMed Web of Science ®Google Scholar
• Madsen M, Rasmussen S, Juel K. Acute myocardial infarction in Denmark. Incidence development and prognosis during a 20-year period. Ugeskr Laeger 2000;162:5918–23.
   PubMedGoogle Scholar
• Bjorkelund C, Andersson-Hange D, Andersson K, Bengtsson C, Blomstrand A, Bondyr-Carlsson D, . Secular trends in cardiovascular risk factors with a 36-year perspective: observations from 38- and 50-year-olds in the Population Study of Women in Gothenburg. Scand J Prim Health Care 2008;26:140–6.
   PubMed Web of Science ®Google Scholar
• Dansk Selskab for Almen Medicin. Forebyggelse af hjertesygdom i almen praksis – med særligt henblik på dyslipidæmi [Prevention of heart disease in general practice – with particular focus on dyslipidaemia]. Copenhagen: Dansk Selskab for Almen Medicin; 1998.
   Google Scholar
• Christensen B. Forebyggelse af iskæmisk hjertekarsygdom i almen praksis [Prevention of ischaemic cardiovascular disease in general practice]. 2nd ed. Copenhagen: Dansk Selskab for Almen Medicin; 2002.
   Google Scholar
• Christensen B. Forebyggelse af iskæmisk hjerte-kar-sygdom i almen praksis [Prevention of ischaemic cardiovascular disease in general practice]. 3rd ed. Copenhagen: Dansk Selskab for Almen Medicin; 2007.
   Google Scholar
• Thomsen T, Christensen B, Hildebrandt P, Iversen HK, Larsen ML, Sillesen H, . Kliniske retningslinier for fore-byggelse af kardiovaskulær sygdom i Danmark [Clinical guidelines for prevention of cardiovascular disease in Denmark]. Tillæg til Cardiologisk Forum August; 2004.
   Google Scholar
• EUROASPIRE I and II Group, European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995–1001.
   PubMed Web of Science ®Google Scholar
• Larsen J, Andersen M, Kragstrup J, Gram LF. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993–1998) in a Danish population. Eur J Clin. Pharmacol 2001;57:343–8.
   PubMed Web of Science ®Google Scholar
• Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of coronary heart disease in primary care: Population-based cross-sectional study using a disease register. J Public Health Med 2003;25:29–35.
   PubMedGoogle Scholar
• Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 2002;36:1532–9.
   PubMed Web of Science ®Google Scholar
• Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G, . The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000;24S6–11.
   Google Scholar
• Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004;47:1566–73.
   PubMed Web of Science ®Google Scholar
• Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998;140:199–270.
   PubMed Web of Science ®Google Scholar
• Bjerrum L. Pharmacoepidemiological studies of polypharmacy: Mmethodological issues, population estimates, and influence of practice patterns. PhD thesis. Odense: Odense University; 1998.
   Google Scholar
• Bach Nielsen KD, Dyhr L, Lauritzen T, Malterud K. Long-term impact of elevated cardiovascular risk detected by screening: A qualitative interview study. Scand J Prim Health Care 2005;23:233–8.
   PubMed Web of Science ®Google Scholar
• Erhardt LR, Hobbs FD. A global survey of physicians’ perceptions on cholesterol management: The From The Heart study. Int J Clin Pract 2007;61:1078–85.
   PubMed Web of Science ®Google Scholar
• Midlov P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, . Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey. Scand J Prim Health Care 2008;26:154–9.
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Laslett L, Diercks D, Kirk JD. Reducing the knowledge-practice gap in the management of patients with cardiovascular disease. Prev Cardiol 2002;5:12–5.
   PubMedGoogle Scholar
• Vægter K, Waldorff FB, Kirkegaard J, Kristensen K. Brug af DSAM's kliniske vejledning om forebyggelse af iskæmisk hjertesygdom i almen praksis. Resultater fra Storstrøms Amt [Use of DSAM's clinical guidelines on prevention of ischaemic heart disease in general practice]. Ugeskr Læger 2000;162:5979–82.
   Google Scholar
• Backlund L, Danielsson B, Bring J, Strender LE. Factors influencing GPs’ decisions on the treatment of hypercholesterolaemic patients. Scand J Prim Health Care 2000;18:87–93.
   PubMed Web of Science ®Google Scholar
• Tonstad S, Rosvold EO, Furu K, Skurtveit S. Undertreatment and overtreatment with statins: The Oslo Health Study 2000–2001. J Intern Med 2004;255:494–502.
   PubMed Web of Science ®Google Scholar
• Heidrich J, Behrens T, Raspe F, Keil U. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists: Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005;12:521–9.
   PubMedGoogle Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398–9.
   Google Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
   PubMed Web of Science ®Google Scholar
• Dalsgaard E, Lauritzen T, Christiansen T, Mai KS, Borch-Johnsen K, Sandbaek A. Socioeconomic factors related to attendance in a Type 2 diabetes screening programme. Diabet Med 2009;26:518–25.
   PubMed Web of Science ®Google Scholar